Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-07

Clinical Trial Update: Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating pentoxifylline as an adjunct to citalopram in adults with major depressive disorder has completed phase 1 and phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)
  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Hawler Medical University | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED